Ann Dowd and ‘Handmaid’s Tale’ Team Tease Upcoming Sequel Series ‘The Testaments’
"We tried not to make the same show — it's got younger voices, it's got a completely different feel and a completely different vibe," creator Bruce Miller says of the new Gilead-set project.
Zacks Investment Research on MSN6h
Gilead Sciences (GILD) Ascends While Market Falls: Some Facts to Note
In the latest market close, Gilead Sciences (GILD) reached $112.39, with a +0.45% movement compared to the previous day. The stock outperformed the S&P 500, which registered a daily loss of 4.84%. On ...
Amazon, Alphabet, KLA And A Health Care Stock On CNBC's 'Final Trades'
On CNBC's “ Halftime Report Final Trades ,” Rob Sechan of NewEdge Wealth said Gilead Sciences, Inc. GILD +0.78% Get Free Report is one of the best-performing names in one of the best-performing ...
Gilead: HIV Franchise Woes Highlight Cancer Follies
Gilead’s HIV franchise generated $19.612B in 2024, but faces future funding challenges. Learn why GILD stock is a "Hold" amid ...
Bernstein Sticks to Its Buy Rating for Gilead Sciences (GILD)
Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences (GILD – Research Report) yesterday and set a price target of ...